Skip to content
Doseworth
Menu

Evidence review

Switching From Compounded to Branded: How Big the Step Really Is

Switching is not one price replacing another. Four charges change at once, and the introductory price you were counting on is usually out of reach.

By Marla Whitfield, Pricing Editor

People switch from a compounded GLP-1 to an FDA-approved one for all sorts of reasons, and almost everyone budgets for it by subtracting one monthly price from another. That is the wrong arithmetic, and it is wrong in a consistent direction: it understates the step.

Four things change at the same time. Only one of them is the drug price.

One: a flat price becomes a ladder, and you enter it at your dose

Compounded sellers overwhelmingly charge a single price whatever strength you are on. Found's pricing FAQ puts it plainly: "Compounded medications are included in the cost of both insurance and cash-pay plans."1 Zealthy sells a flat "Semaglutide Bundle: $217 for your first month, then $297 per month".2

Branded pricing is not flat. LillyDirect charges $299 a month for Zepbound® at 2.5 mg, $399 at 5 mg and $449 at 7.5 mg and above.3 Novo charges $349 for most Wegovy® pen doses and $399 for the 7.2 mg high-dose pen.4

Here is the part people miss. If you have been on a compounded product for a year, you are not starting a branded course at the bottom of the ladder. You arrive at whatever tier your current strength maps to. The $299 entry price on the tirzepatide ladder is a starting-dose price, and a switcher generally never sees it.

Two: the introductory offer is probably not available to you

Novo's $199 pen price looks like the obvious landing spot for a switcher. Read the footnote: "Patients new to Wegovy® Savings Offer & NovoCare® Pharmacy pay $199 for each month of 0.25 mg and 0.5 mg. Offer for 2 monthly fills through December 31, 2026."4

Two conditions, and most switchers fail at least one. It applies only to the 0.25 and 0.5 mg doses — the two lowest — so anyone arriving at a higher strength pays $349 from the first fill regardless. And it applies only to patients new to the offer and to NovoCare Pharmacy.

The Ozempic® pen offer carries the same two restrictions.5

Three: the membership may not go away

This is where the sentence from Found's own FAQ earns its place. The full quote: "Compounded medications are included in the cost of both insurance and cash-pay plans. Branded GLP-1 medication may also be available but their cost is billed separately and isn't included in the prices listed above."1

Read that as a bill. Before the switch, $289 a month buys care and medication. After the switch, $289 a month buys care, and the medication is a second charge on top. The plan price does not fall to make room for it.

The same shape shows up at telehealth companies that resell branded product directly. Ro charges $39 to start and then $149 a month for the care layer, on top of a medication line that runs $299, $399 or $449 for Zepbound — $598 a month all-in at the top tier.6 Our Ro review and Found review take both bills apart.

Four: the length of a month changes

Compounded and branded products are not billed on the same clock, and the mismatch shows up as an extra fill you did not plan for.

LillyDirect defines a Zepbound month as 28 days, so 365 days holds about 13 fills.3 A Novo pen month is one box of four weekly pens — also 28 days. A Novo tablet month is one bottle of 30 tablets, so about 12.2 fills. Found bills monthly plans at $289.1

Multiply the wrong number by twelve and a Zepbound year comes out $449 light.

The cheapest version of this switch, and the dearest

Two switchers, same starting point — a compounded plan at roughly $289 a month, or about $3,468 over twelve cycles.

Cheapest: switch to the branded Wegovy tablet and settle at its maintenance tier of $299 a month over twelve 30-day fills. That is $3,588 a year. The step is $120 for the year — about ten dollars a month for a product with an FDA approval behind it.

Dearest: switch to branded Zepbound resold through a telehealth membership at $598 a month all-in. Over a year that is $6,916. The step is $3,448.

Both switches move a reader from a compounded product to an FDA-approved one. One costs ten dollars a month. The other costs nearly three hundred. The variable is not the molecule; it is the form and the channel.

What does not change

The clinical reason you are switching, which is not ours to comment on. And your plan's cost sharing, which no first-party source publishes per drug — so nothing above is an insured price.

It is also worth noting what you gain, in the FDA's own framing rather than ours: compounded drugs "are not FDA-approved", the agency "does not verify the safety, effectiveness or quality of compounded drugs before they are marketed", and a compounded drug is not the same regulatory object as a generic, which must establish therapeutic equivalence.7 Whatever the step costs, that is what it buys.

What we could not price

We could not price Found's branded GLP-1 route, because Found states that branded medication is billed separately and does not publish the figure. The $289 above is therefore a floor for that switch, not a total.

We could not verify whether any compounded seller offers a transition credit or a prorated final cycle, because none of the pages we read describes one.

And we could not price the Wegovy 7.2 mg high-dose pen against a compounded equivalent, because no compounded seller we priced publishes a strength-matched product.

Related: compounded semaglutide vs branded Wegovy, compounded tirzepatide vs branded Zepbound, and the live spread on the compounded semaglutide board.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S; Zepbound® is a registered trademark of Eli Lilly and Company.

Frequently asked questions

How much more does branded cost than compounded?

Anywhere from about ten dollars a month to nearly three hundred, depending entirely on which branded product and which channel. Moving from a $289 compounded plan to the branded Wegovy tablet at its $299 maintenance tier is a $120 step across a year. Moving to branded Zepbound resold through a telehealth membership at $598 a month is a $3,448 step across the same year.

Can I get the $199 introductory price when I switch to Wegovy?

Usually not. Novo's footnote restricts it to patients new to the Wegovy Savings Offer and to NovoCare Pharmacy, and to two monthly fills of the 0.25 and 0.5 mg doses only. A switcher arriving at a higher strength pays $349 from the first fill even if they have never used the offer. The Ozempic pen offer carries the same two restrictions.

Does my telehealth membership fee go away when I move to a branded drug?

Not necessarily. Found states that compounded medications are included in its plan price but that branded GLP-1 medication is billed separately and is not included in the prices listed. On that structure the plan fee continues and the drug becomes a second charge. Ro's care fee behaves the same way, at $149 a month on top of a $299 to $449 medication line.

Why does a branded year cost more than twelve times the monthly price?

Because branded injectables are sold in four-weekly quantities. LillyDirect defines a Zepbound month as 28 days and a Novo pen month is a box of four weekly pens, so a 365-day year holds about 13 fills rather than 12. Branded tablets are the exception — a 30-tablet bottle gives about 12.2 fills a year.

References

  1. Found Health, Inc. (2026). Plans and pricing, including the medications-included FAQ (read 7 August 2026). joinfound.com. https://joinfound.com/plans-and-pricing
  2. Zealthy Inc. (2026). Weight loss pricing FAQ (read 7 August 2026). getzealthy.com. https://getzealthy.com/weight-loss-faq
  3. Eli Lilly and Company (2026). Zepbound self-pay pricing, LillyDirect (read 7 August 2026). lilly.com. https://www.lilly.com/lillydirect/zepbound
  4. Novo Nordisk (2026). Wegovy price guide, document US26NC00049 (April 2026). novocare.com. https://www.novocare.com/content/dam/novonordisk/novocare/redesign/pdf/Wegovy_Price_Guide.pdf
  5. Novo Nordisk (2026). Ozempic pill and pen price guide, document US26NC00009 (May 2026). novocare.com. https://www.novocare.com/content/dam/novonordisk/novocare/redesign/pdf/Ozempic_Price_Guide.pdf
  6. Roman Health Ventures Inc. (2026). Zepbound product and pricing page (read 7 August 2026). ro.co. https://ro.co/lp/weight-loss/zepbound/s/pdp/
  7. US Food and Drug Administration (2025). Compounding and the FDA: questions and answers. FDA.gov. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.

Continue reading